The annual meeting of the Society of Nuclear Medicine and Molecular Imaging (#SNMMI) takes place in Anaheim, California this year on June 22-25. Each year the event attracts more than 5,000 participants from all over the world representing hospitals, academia and industry. MedTrace participates this year with a small booth and is excited to present our first full 15O-water installation at Aarhus University Hospital and the plans for manufacturing even more hardware units.
During the conference, MedTrace will take part in a panel debate regarding commercialization of new technologies, and our scientists have new exciting oral presentations on cardiac perfusion.
We are also thrilled about the line-up of meetings that have been pre-booked with cutting-edge imaging vendors from across the globe as well as leading clinicians from Japan, Europe and the US.
Before the show starts, we have also gathered our all-star team of clinical investigators to discuss our upcoming phase III trial in collaboration with our Boston-based CRO, Cardiovascular Clinical Services Foundation (CCSF).
